Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 7,471 shares at $4.05 ($30K) on 2025-01-06, disclosed to the SEC on 2025-01-08.
Seasonal sale ($30k) by Co-Chief Executive Officer — this insider has traded AMLX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |